OR7A10: A Potential Drug Target and Biomarker for Olfactory Receptor Function
OR7A10: A Potential Drug Target and Biomarker for Olfactory Receptor Function
Smell is a crucial sense that many people use to perceive the world around them. It helps us identify and remember important things, and it plays a significant role in our overall quality of life. The olfactory receptor, OR7A10, is a protein that is responsible for transmitting smell information from the sense of smell to the brain. In recent years, researchers have made significant progress in understanding the role of OR7A10 in various biological processes, including pain perception, anxiety, and depression. This has led to the potential development of OR7A10 as a drug target and biomarker.
OR7A10 is a member of the olfactory receptor family, which includes over 400 different proteins that are responsible for transmitting smell information from the sense of smell to the brain. These proteins are found throughout the body, including in the sense of smell, the nasal cavity , and the brain. OR7A10 is a 26-kDa protein that is expressed in the mouse olfactory system, including the olfactory epithelium and olfactory neurons.
OR7A10 is involved in the perception of a wide range of stimuli, including scents, such as those associated with food, sex, and other environmental stimuli. It is also involved in the regulation of pain, anxiety, and depression. For example, studies have shown that OR7A10 is involved in pain perception and that it can interact with other pain-related genes, such as TRPV1.
In addition to its role in pain perception, OR7A10 is also involved in the regulation of anxiety and depression. For example, research has shown that OR7A10 is involved in the regulation of anxiety-like behavior, and that it can interact with other anxiety-related genes, such as GABA. Additionally, OR7A10 has been shown to be involved in the regulation of depression-like behavior, and that it can interact with other depression-related genes, such as DBP.
OR7A10 is also involved in the regulation of various physiological processes that are critical for maintaining brain health and function. For example, it is involved in the regulation of blood flow to the brain, and it has been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's disease. Additionally, OR7A10 is involved in the regulation of neuroplasticity, and has been shown to play a role in the development of various neurological disorders, including depression, anxiety, and pain.
Due to its involvement in a wide range of physiological processes, OR7A10 is a promising drug target and biomarker. Studies have shown that blocking OR7A10 can have a variety of therapeutic effects, including the inhibition of pain, anxiety, and depression. Additionally, blocking OR7A10 has been shown to have a variety of non-therapeutic effects, including the regulation of blood flow to the brain and the development of neuroplasticity.
In conclusion, OR7A10 is a protein that is involved in the perception of smell and the regulation of a wide range of physiological processes that are critical for maintaining brain health and function. Its potential as a drug target and biomarker makes it an attractive target for further research and development. Further studies are needed to fully understand the role of OR7A10 in various biological processes and to determine its potential as a therapeutic agent.
Protein Name: Olfactory Receptor Family 7 Subfamily A Member 10
Functions: Odorant receptor
The "OR7A10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR7A10 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1 | OR9K2 | OR9Q1 | OR9Q2 | ORAI1 | ORAI2 | ORAI3 | ORC1 | ORC2 | ORC3 | ORC4 | ORC5 | ORC6 | Orexin receptor | Organic anion transporters (OATs) | Organic cation transporter | Origin recognition complex | ORM1 | ORM2 | ORMDL1 | ORMDL2 | ORMDL3 | OS9 | OSBP | OSBP2 | OSBPL10 | OSBPL11
